Abstract
Background Canada provides universal access to health-care, but the extent of inequalities in the direct medical costs of asthma across different socio-economic status (SES) groups and its trends over time remain unclear. To characterize SES-related differences in the direct costs of asthma and the trends in a universal health-care system, and explore the patterns of costs for asthma medication as potential determinants of these SES-related inequalities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have